Leadership Transition TRACON Pharmaceuticals recently appointed Craig R. Jalbert as the new CEO. This leadership change presents a potential sales opportunity for businesses looking to establish new partnerships or collaborations with the company.
Product Development The development of Envafolimab by TRACON Pharmaceuticals indicates a focus on innovative products. Businesses offering complementary services or products in the oncology sector may find potential sales opportunities by aligning with TRACON's product roadmap.
Financial Investment TRACON Pharmaceuticals secured a significant $35 million debt facility for its ongoing trials and corporate initiatives. Financial service providers or investment firms could explore collaboration opportunities to support TRACON's growth and expansion.
Board Expansion With the appointment of Carol Lam to its Board of Directors, TRACON Pharmaceuticals showcases a commitment to diverse expertise. Companies specializing in board governance consulting or advisory services may find avenues for sales engagements with TRACON.
Talent Acquisition TRACON Pharmaceuticals continues to strengthen its team by hiring top industry professionals like Brenda Marczi and Ya Huang. HR consulting firms or talent acquisition agencies could leverage these hiring trends to offer their services to TRACON or similar companies in the biopharmaceutical sector.
169
$10M$50M
51$10M$50M
51$10M$50M
51$10M$50M
1.7K$100M$1B
12TRACON Pharmaceuticals uses 8 technology products and services including MySQL, Shopify, Backbone.js, and more. Explore TRACON Pharmaceuticals's tech stack below.
| TRACON Pharmaceuticals Email Formats | Percentage |
| FLast@traconpharma.com | 86% |
| FirstL@traconpharma.com | 9% |
| First@traconpharma.com | 3% |
| First.Last@traconpharma.com | 2% |
Biotechnology ResearchUnited States11-50 Employees
TRACON is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and utilizes its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States.
Company Overview
Media & News
Funding & FinancialsTRACON Pharmaceuticals's revenue is in the range of $10M
Funding & FinancialsTRACON Pharmaceuticals's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com